Mapping chest wall perforators for partial breast reconstruction
Official title: Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast Reconstruction (LaPBrecon)
Run by University Hospitals of North Midlands NHS Trust · NCT07006662 · Data updated 2026-11-12
This study tests how chest wall perforator locations relate to body landmarks in women undergoing breast-conserving surgery to help guide perforator flaps for reconstruction.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospitals of North Midlands NHS Trust Academic / other |
| Locations | 1 site (Stoke-on-Trent) |
| Status | Recruiting |
| Started | August 4, 2026 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT07006662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older undergoing elective breast surgery with BMI ≤ 30 kg/m2, who are willing to consent and comply with study procedures.
✕Probably not a fit
Patients who do not undergo perforator-based reconstruction or whose anatomy does not rely on the studied perforators may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This 6-month proof-of-concept study aims to map chest wall perforators used in partial breast reconstruction to nearby anatomical landmarks. Eligible participants are women undergoing elective breast surgery with BMI ≤ 30 kg/m2 who will have a 30-minute assessment using a hand-held Doppler to identify perforators and relate their positions to soft tissue and bony landmarks. Data will be analyzed to identify common anatomical locations for thoracodorsal, lateral thoracic, and intercostal perforators to potentially streamline intraoperative localization. The study focuses on improving cosmetic outcomes after breast-conserving procedures by clarifying perforator anatomy. No interventions are described beyond the mapping assessment.
Why it matters
Potential benefit: If successful, the findings could help surgeons quickly locate reliable perforators during reconstruction, potentially improving cosmetic results and reducing operative time.
How similar studies have gone: Previous cadaveric and intraoperative work informed perforator anatomy, but this study adds live, patient-specific landmark mapping to guide practice.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing elective breast surgery * Age ≥ 18 years * Female * BMI ≤ 30 kg/m2 * Willing and able to give fully informed consent, * Willing and able to comply with the study procedures Exclusion Criteria: * Pregnant patients * Previous bilateral Breast or axillary surgery * Undergoing bilateral oncoplastic procedure or requiring bilateral pre-operative marking * Undergoing breast surgery requiring pre-operative marking of some of the landmarks and has had contralateral breast or axillary surgery in the past * Surgery planned within 24 hours of screening for eligibility * Known history of allergy or contact dermatitis to ultrasound gels
Where it's running
-
University Hospitals of North Midlands NHS Trust
Stoke-on-Trent, United Kingdom Recruiting
Study contacts
- Study coordinator: Aviva Ogbolosingha
- Email: aviva.ogbolosingha@uhnm.nhs.uk
- Phone: 01782675380
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
Negative pressure wound therapy after mastectomy
This study tests whether a negative pressure dressing after mastectomy reduces fluid build‑up and common wound complications in women with breast cancer.
-
ATUSA 3D automated breast ultrasound for suspicious breast lesions
This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.
-
Support tool for women with HR+ breast cancer on long-term endocrine therapy
This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.
-
Conformal ablative radiotherapy for older women with localized ER-positive, HER2-negative breast cancer choosing non-surgical care
This study will test whether five focused SABR treatments can control ER-positive, HER2-negative breast tumors up to 5 cm in women aged 65 and older who are opting for non-surgical management.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.